The taskforce was established following the EU referendum result on 24 June, with the central purpose of putting the profession in charge of its future by maximising the opportunities and minimising the risks of Brexit.
Almost half of veterinary surgeons registering in the UK qualified from veterinary schools elsewhere in the EU. While the Government issued a statement in mid-July clarifying that as yet there has been no change to the rights and status of EU nationals in the UK or UK nationals in the EU, it is not clear whether this situation will continue once the UK has left the EU.
The Brexit Presidential Taskforce will consider, and proactively engage with, the many possible changes that could shape the future of the UK veterinary profession due to Brexit.
The members of the Taskforce are: the President of the College, Chris Tufnell; the CEO, Nick Stace; the Treasurer, Amanda Boag; Operations Director, Corrie McCann; Junior Vice-President, Stephen May; Acting Registrar, Eleanor Ferguson; Chair of Education, Susan Dawson; Head of Education, Chris Warman; Council member Stuart Reid; Chair of VN Council, Liz Cox; and Director of Strategic Communications, Lizzie Lockett.
The terms of reference include: considering how EU regulations currently impact the regulation of veterinary professionals in the UK, and making recommendations as to which should be maintained; looking at the issue of mutual recognition of veterinary graduates in Europe; considering workforce requirements and the implications of a new system of immigration; understanding the implications for the current RCVS agenda; considering whether a proactive RCVS agenda can influence any new UK legislation; reconsidering the College’s existing international strategy; and studying the financial impact on the College.
It was also agreed that the College should maintain communications with the British Veterinary Association and coordinate approaches where appropriate.
Dr Chris Tufnell, President of the RCVS, said: "Brexit has profound implications for our professions. The Presidential Taskforce is exploring all implications and will develop proposals that will seek to mitigate the risks and maximise the benefits that can flow to the veterinary professions and to animal welfare.
"We are working closely with representative bodies and others so that the veterinary professions have a coordinated and well executed plan in place. We are in discussions with all relevant Government departments, working collaboratively and constructively, ensuring that our voice is heard and our influence is felt."
The next meeting will be held on 15 September, with the third one scheduled for 9 November.
Located in the South East of England, the centre is part of the new School of Veterinary Medicine at the University of Surrey, and one of the UK's largest veterinary pathology centres, offering high-containment post-mortem examination facilities and histopathology.
The centre is staffed by a team of board-certified veterinary pathologists, veterinary investigation officers and technicians, with expertise in farm-animal, equine, exotic and small-animal pathology.
The new building centres on a large containment level 2 post-mortem examination room with high ceilings, natural lighting, post-mortem examination tables, biological safety cabinets and integrated cold rooms, all served by a powerful winch system which means that post-mortem examinations can be performed on a wide range of species. A viewing gallery overlooks the suite and post-mortem examinations can be recorded and streamed for training purposes.
Professor Roberto La Ragione, Director of the Veterinary Pathology Centre, said: "Veterinary pathology is a growing discipline and its importance has been highlighted in recent disease outbreaks and the important role veterinary pathologists make in drug development. Helping the farming community to be more effective, sustainable and innovative, the Centre will work with partners, businesses and researchers to address some of the unique challenges faced by the veterinary and scientific community.
"It is the close relationships with our external clinical and scientific partners that enables us to be innovative in our approach to education and training here at the Surrey. An example of the latter is the use of digital pathology in teaching, research and diagnostics, which was the subject of discussion at the recent launch of the Veterinary Health Innovation Engine (vHive).
"Together with our partners such as the National Physical Laboratory and the 5G Innovation centre, the Centre is at the forefront of the digitalisation of pathology and innovative big data management.
"The Centre offers the opportunity to inspire the next generation of veterinary pathologists and complements the centres of excellence that already exist in other vet schools and research institutes."
Hosted by Nick Steele, National Consulting Manager at Zoetis and Rachael Whittle, a business coach specialist, the course will present the best techniques to analyse mixed personalities that cause problematic situations, allowing staff to deal with difficulties that may occur on a daily basis. Nick will use his knowledge from working at the world’s largest global animal health company, while Rachael will use her experience in business training and coaching to help anyone that works with people on a daily basis manage these daily challenges, using common examples from their own background.
For the chance to win a free place at this event, send an email with your name, the name of your veterinary practice and the reason attending this course will help grow your practice’s business to royalcaninvet.gbr@royalcanin.com.
Royal Canin will select three applicants at random, and will inform the winners via email, by Thursday 30 June.
Places on the course can also be booked by calling 01453 872731 or by visiting www.spvs-vpma-events.co.uk. Workshops cost £265 plus VAT for non-members and £190 plus VAT for VPMA and SPVS members (group/ bulk booking discounts are also available). Cost includes CPD certificates, lunch and refreshments.
1004 veterinary professionals attended VET Festival to hear talks from a line up of 21 speakers from around the world. On the Friday night, VETFest Live provided an opportunity for delegates to network and relax in front of a number of acts, including Hunter and the Bear, Lucy Spraggan and Morrissey & Marshall.
Noel said: "I think that change is inevitable within veterinary education. My experience with the students of today is that they wish to embrace new learning formats and are especially enthusiastic about learning environments where didactic lectures become an immersive experience. My goal therefore was to achieve the perfect mix of education and a chilled-out festival atmosphere.
"We are learning all the time, and we invite suggestions. I take very seriously the commitment I voiced in the welcome address, which is to reinvest every penny for the greater good for animals and the profession. I sincerely believe that vets and vet nurses will over time question where their money is spent and will take a good hard look not only at what value they get for their investment, but also where their money actually goes."
Picture: Richard Dunwoody.
Zoetis has announced that a batch of the bluetongue vaccines, Zulvac® 8 Bovis and Zulvac® 8 Ovis, is expected to become available to veterinary practices in mid-July, in time to manage the risk of an outbreak predicted by Defra to reach mainland UK by the late summer.
The company says the quantity of vaccine will not be unlimited and that it will strive to achieve as widespread availability as possible.
The two vaccines (Bovis for cattle and Ovis for sheep) are licensed to “prevent viraemia” caused by bluetongue virus serotype 8 (BTV-8). Prevention of viraemia, the presence of bluetongue virus in the blood, ensures no onward spread of infection via the blood sucking Culicoides midge.
The vaccines can be used in cattle from three months of age, or six weeks in sheep, requiring two doses three weeks apart in either species. Each dose is 2ml administered intramuscularly in cattle or subcutaneously in sheep, and onset of immunity is 25 days after the second dose. The vaccine provides immunity for a full 12 months.
The British Veterinary Association (BVA), British Cattle Veterinary Association (BCVA), Goat Veterinary Society (GVS), and Sheep Veterinary Society (SVS) welcomed the announcement from Zoetis, and another from MSD, but sought clarification about the cost and the amount of vaccine likely to be available in July and thereafter.
BVA President Sean Wensley said: "We welcome the announcement that vaccine will be available in time to meet potential demand. This disease seriously affects animal health and welfare as well as the productivity of livestock, and vaccination is the key control. While it is good news that vaccine will be available, we know that both farmers and vets will have questions about cost and whether there will a limit to the amount of vaccine available in July. It would be helpful to have these questions clarified as soon as possible."
Photo by Fourrure (http://www.boulesdefourrure.fr) [CC BY-SA 2.0], via Wikimedia Commons
Effipro Duo contains fipronil to kill adult fleas and ticks, and pyriproxyfen, an insect growth regulator, to sterilise adult fleas and inhibit the immature life stages. It provides three months protection against flea life cycle completion.
The product is presented in Effipro’s patented ‘drop-lock’ pipette, designed to ensure that the solution is released only when the owner is ready.
Effipro Duo is offered in packs of 4 pipettes and in a 24-pipette dispensing pack to suit practices offering health plans.
Product Manager Kate Woolley MRCVS said: "Because Effipro Duo targets not just the adult fleas on the pet but also the key developmental stages in the flea life cycle often found in the home, it represents an integrated and easy-to-use solution, both for on-animal flea and tick control and for long-lasting protection of the home environment.
"Household flea infestations are common all year round and experts agree that the combination of an adulticide and an insect growth regulator is the most effective way for owners to protect their homes from this unpleasant problem¹. For complete flea control in the home, we recommend that it is used in conjunction with Indorex®, the UK’s no. 1 household flea spray².
"Virbac offers one of the most extensive parasiticide ranges on the market and we believe Effipro Duo will provide a popular addition, offering owners long-lasting protection from fleas and ticks for their cats and dogs, while helping practices to retain vital parasite control sales in-house."
References
James Hutchings, Head of Sales for Bimeda UK, said: "The launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price."
Bimeda says the benefits of Tetroxy Vet include:
Tetroxy Vet is available in a 100ml pack size.
NOAH’s Office Manager Joanne Jeffs said: "We know more people are accessing the site using mobile technology and in order that the site can be viewed more easily on mobile phones and tablets as well as traditional desktops, we needed to move the whole complex set of data to a new web platform.
"This is only one of the advantages of the move – it will enable us to finalise our Compendium app, for example, and further down the line will enable more bespoke information access to become available via an API* feed – and we needed to take this major step for progress to be made.
"The most important thing was to maintain the integrity of the data – prescribers and users of animal medicines rely on its accuracy to make their prescribing decisions and guide responsible use. We know this has been done.
She added: "With the move, we know there are some post launch issues that we are addressing. We are working on those as quickly as we can. We know users need to print datasheets, for example and this function will soon be back online. We welcome all feedback and thank all our users for their patience.
www.noahcompendium.co.uk
The College says it has become increasingly recognisant of how a blame culture can lead to a fear of making mistakes, something which can have a negative impact on both the mental health and wellbeing of members of the profession and, ultimately, animal health and welfare.
The anonymous online survey, which is being conducted by the Open Minds Alliance, is described by the College as a major step towards moving to a learning culture which has a greater focus on openness, reflective practice, learning and personal development.
Nick Stace, RCVS Chief Executive Officer, said: "Moving towards a learning culture is one of the key aims of our Strategic Plan 2017-19 and we have already started to make some progress in this area with our Mind Matters Initiative, for example. This survey will help establish a baseline against which we can measure any improvements over the course of the next three years.
"As a regulator this is part of our attempt to be much clearer about the kind of culture we would like to see in the professions; one that encourages members of the veterinary team to learn from each other, and from their mistakes, and to be more open about when things do go wrong in order to better manage public and professional expectations.
"By moving towards a learning culture we can also hopefully reduce levels of stress and mental ill-health within the profession, as practitioners will feel they can be more open about their mistakes and take steps to improve their practice – rather than feeling like they cannot talk about what goes wrong, which can lead to fear and anxiety.
"This is no easy task – particularly when public expectations of what veterinary surgeons and veterinary nurses can and should do is increasing – but we hope that by being brave and open about this new ambition we can galvanise veterinary associations, educators, practices and individual veterinary surgeons and veterinary nurses and make a real difference."
The survey will also be asking to what extent members of the profession feel that the College, as the regulator, contributes to any blame culture and where improvements could be made to the concerns investigation and disciplinary process to help combat it.
Eleanor Ferguson, RCVS Registrar and Director of Legal Services, added: "It is a common misconception that if you make a mistake then this will be investigated by the College and you will end up in front of a Disciplinary Committee.
"However, we recognise that mistakes can and will happen and that expecting 100% perfection is unrealistic. The real professional conduct issues arise when members of the profession try to cover up their mistakes, whether that is to professional colleagues or clients, which often does far more damage than if the person was open and honest about what had gone wrong.
"We do also accept that there is always room for improvement in our own processes and if there are positive steps we can take to make the investigation and disciplinary process less onerous for members of the professions then we would like to hear your suggestions."
Click here to take part in the survey.
The Veterinary Hospital and Surgery acquired the Magdalen Arms in late 2014 and started work on the conversion of the listed building in March 2015, with particular care needed to preserve original features including its Dutch gables and the falcon logo of local brewery Lacon’s, which is incorporated into the brick work.
The new hospital was officially opened at the end of February, with the Mayor of Great Yarmouth, Malcolm Bird, and local 2012 Paralympic gold medallist Jessica-Jane Applegate unveiling the plaque. More than 1,000 local people came to have a look round, many bringing their canine friends.
Clinical Director Elissa Norman said: "In recent years we had outgrown our original surgery and it started to become difficult to offer the level of service we wanted to within the space we had.
"We knew that the Magdalen Arms, in addition to being a well-known local landmark, offered all the space we needed, a central location and plenty of parking. The structure of the building made the conversion quite complex but the final result is beyond our expectations and we can’t wait to see the reaction of our clients when they bring their pets to us for the first time."
"We now have staff on site with patients 24 hours a day, 365 days of the year, plenty of parking and we can offer full access for disabled clients all of which were a priority for us. The reception area is spacious and inviting, the consult rooms are well equipped and the new cat ward will create a less stressful environment for our feline patients.
"Watching this much-loved building take shape as a brand-new hospital with all the facilities we need for our patients, their owners and our staff has been special and I’m looking forward to helping it take on a different role within the community. While the building work is now finished, we have lots of plans to develop the service we offer further over the next few months."
"We are grateful to the Mayor Malcolm Bird and to Jessica-Jane for helping us celebrate the opening of the hospital and it was great to welcome so many local people and show them around as they have been so supportive during the conversion. It is clear that the building holds a strong place in many of their memories but that they are as excited as we are to see the amazing transformation that has taken place. We look forward to serving them and caring for their pets in the years ahead."
ISFM points to an editorial published ten years ago in The Lancet (Hypertension: uncontrolled and conquering the world), which presented alarming facts about hypertension in people: the risk of becoming hypertensive during a lifetime exceeds 90% for people in developed countries, with over 1.5 billion adults expected to have hypertension by 2025. It also said: 'screening is not done systematically, and the diagnosis is often made at a late stage when target organ damage has already happened'.
The Society says there are broadly similar concerns in our feline companions. Hypertension is a well-recognised condition in older cats, yet probably remains significantly underdiagnosed. The consequences can be severe, with target organ damage typically affecting the eyes, heart, brain and kidneys. Some damage, such as blindness resulting from complete retinal detachment, is irreversible. Other damage, however, is more amenable to antihypertensive treatment, highlighting the importance of early diagnosis and intervention. However, this presents challenges, particularly as routine blood pressure monitoring is generally performed infrequently in cats. Furthermore, cats are notoriously susceptible to stress in the veterinary clinic, which can lead to 'white coat hypertension' and hamper interpretation of results.
The new ISFM consensus guidelines are published in its Journal of Feline Medicine and Surgery1. The recommendations are those of an expert panel of veterinary clinicians and academics gathered from the UK, Australia, New Zealand, Spain, France and the USA, and cover several key areas. They include: how often to monitor blood pressure for cats of different ages and health status; when antihypertensive therapy is justified based on different systolic blood pressure readings and evidence of target organ damage; and what an investigation of hypertensive cats should include.
Samantha Taylor, a specialist in feline medicine and one of the co-chairs of the guidelines panel, said: "Well-illustrated and easy to read, it is hoped that these guidelines will encourage more widespread monitoring of blood pressure in veterinary clinics to increase the early identification of this treatable condition, and prevent the severe clinical consequences of untreated hypertension."
Accompanying the guidelines, which are endorsed by the American Association of Feline Practitioners, are further resources to assist veterinarians with the diagnosis of hypertension. A blood pressure evaluation form can be downloaded from the supplementary material; in addition, a series of short videos produced by the ISFM on measuring blood pressure in cats is available in various languages at https://www.youtube.com/user/iCatCare/playlists.
Reference
During the race, which runs between Johannesburg and Durban in April 2017, Jason and Paul will cover 900km (559 miles) on their velocipedes.
They're raising money for a charity called Chipembere Rhino Foundation, a charity which works to monitor rhino and curb poaching. According to the charity, there are 20,000 African white rhino and 4,800 African black rhino remaining, which classifies them as ‘near-threatened’ and ‘critically endangered’ respectively. Against that background, poaching levels have reached crisis point, with 2,700 rhinos killed between 2000 and 2013, and a further 1215 in 2014 alone.
The importance of the charity's work was further highlighted today after news that poachers have shot an African white Rhino for its horn at Thoiry Zoo outside Paris.
Jason said: "We are living in a world where our natural resources, from water and minerals to animals and plants, are becoming increasingly rare and as a result they are highly prized and valuable. Habitat destruction and poaching are two of the greatest risks facing the world's wildlife. Rhinos are being killed for their horns, elephants for their tusks, pangolins for their scales and now even donkeys are being killed for their skins. We only have one planet and we all need to do what we can to protect it."
If you’d like to support Jason and Paul in their efforts, you can do so at http://www.justgiving.com/teams/rhinocycle
Underlying the plan are three 'Brexit Principles', devised by the College and formally adopted by RCVS Council, which will guide the College’s relationship with the Government during the forthcoming Brexit negotiations.
The College says each Principle is supported by a number of specific policies that the College will lobby for in the coming months, all designed to positively engage with the post-referendum reality and with government policy.
The Principles are:
RCVS Chief Executive Nick Stace said: "It is crucially important for the College and the profession as a whole to think boldly about the post-Brexit future; we cannot expect government to give us all of the answers, instead we must work to find solutions ourselves so as to shape the future of the profession from within."
The College has also asked the Institute for Employment Studies (IES) to undertake research into the attitudes and intentions of all EU-graduated veterinary surgeons and veterinary nurses currently working in the UK. They will all have receive a personalised email from IES with a link to this online survey, and their answers will help inform the College’s approach to Brexit. This research will help the College to understand better the impact that Brexit may already be having, how it can support EU veterinary professionals working in the UK, and build an evidence base regarding the potential impact that Brexit may have on the veterinary workforce.
For more information on the College’s Brexit activities, visit: www.rcvs.org.uk/brexit
The company, which until now has only offered loans to practice clients for veterinary treatment, is now offering practice staff loans of £1,000-£25,000 for periods ranging from 1-5 years at an APR from 7.9%, with joint applications acceptable.
Stewart Halperin, BVMS, MRCVS, founder and CEO of CarefreeCredit (pictured right), said: "I first started the company to enable other vets to provide interest-free loans to clients facing large bills for uninsured pets.
"Since then, I’ve been thinking of other ways to help practice staff in our profession and realised a quick and simple low-cost loan facility would be a great way to go beyond helping their clients to helping the staff themselves in their daily lives.
"Now, with just a simple phone call taking just 5 minutes, veterinary staff can easily access the finance they want for whatever purpose they need."
For further information call 0345 313 0177.
Dechra says phenobarbital is effective as a monotherapy in 60 to 80 per cent of dogs with idiopathic epilepsy, but that in 40% of dogs, seizures cannot be controlled with phenobarbital alone. In these cases the company's potassium bromide treatment Libromide, is licensed to be used alongside Soliphen as a concurrent therapy.
According to the company, the combination of phenobarbital and potassium bromide has been shown to reduce seizure number and severity in dogs with refractory idiopathic epilepsy; in tests, the combination treatment reduced the mean seizure rate from 27.4 seizures per month to 2.2 seizures.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Epilepsy is the most common chronic canine neurological disorder, affecting around 0.62 per cent of dogs.
"It can be a distressing condition for both the animal and its owner so we are launching a therapy that can reduce the number of seizures in even the most challenging cases.
"We have also produced new guidelines for prescribing vets, detailing step by step how the treatments can act alone or concurrently. We believe using Soliphen as a sole therapy or in conjunction with Libromide will make a positive contribution to veterinary professionals in their ongoing treatment and management of dogs with epilepsy."
For more information, visit www.dechra.co.uk
The guide reviews the definition and classification of pyoderma, history-taking and clinical examination, and diagnostic testing techniques. It also reviews current thinking on therapy options. Bayer says it hopes the practical and evidence-based guide will be an invaluable resource in veterinary practices.
Ross said: "With pyoderma cases appearing almost daily in veterinary consultations, it is vitally important that vets are well versed in treating cases appropriately and efficiently, particularly to ensure the responsible use of antimicrobials. Canine pyoderma commonly poses diagnostic challenges, due to its varied clinical presentation and tendency to be super-imposed on other skin diseases. We envisage that the article will provide readily accessible, clear and practical advice on diagnosing and treating the condition."
Bayer has also launched a new Veraflox website, where the first and second guides in the Education Now, Safeguarding Antimicrobials series (written by Simon Tappin, Head of Medicine at Dick White referrals, Matt Jones, Head of Microbiology at IDEXX, and Ross Bond), are also available for download in the Vet Training Centre section.
The website also offers a number of other resources in the Vet Training Centre, including webinars, case studies and videos.
Hannah Watts, Group Product Manager at Bayer, said: "The new Veraflox website has been built with the practical needs of vets in mind. We hope this will become a frequent resource for helping them overcome daily challenges in diagnosing and treating cases with an appropriate antimicrobial product."
In addition to being available for download at www.veraflox.co.uk, Focus on Pyoderma is also available in print by contacting your Bayer Territory Manager.
Biogal’s CEO, Mr Amos Gershony said: "We placed a large effort behind creating these videos, so that our customers could visualize how simple it is to receive a PCR result in 1 hour."
The videos are:
The recategorisation means that pharmacists and Suitably Qualified Persons (SQPs) will be able to prescribe Zolvix.
The VMD says that making the anthelmintic more widely available will increase its usage as part of strategic worm control programmes on farms, which could in turn result in long term health benefits for sheep, for example by reducing the development and spread of anthelmintic resistance, thereby prolonging the effective use of anthelmintics.
The VMD adds that SQPs will now have additional training to ensure they are sufficiently familiar with Zolvix and how to prescribe it effectively and responsibly so that it is used appropriately. A new compulsory training module will be implemented by The Animal Medicines Training Regulatory Authority (AMTRA) to augment the skills of all AMTRA-registered SQPs permitted to prescribe farm animal products. New SQPs will be required to undertake a revised and extended module before gaining their farm animal registration with AMTRA.
Pharmacists and SQPs will be able to prescribe Zolvix from 1st July 2017.
UPDATE 16th March:
BVA President Gudrun Ravetz has issued a statement expressing concern over the recategorisation of Zolvix:
"We know that resistance to anthelmintics is increasing in grazing animals and needs to be addressed if the livestock industry is to avoid a potentially disastrous situation of being unable to tackle parasites. The reclassification of Zolvix from POM-V to POM-VPS is in direct opposition to the trend in Europe, where we are seeing increased control over dispensing of anthelmintics in species where resistance is a serious threat to animal welfare and profitable production; we're extremely concerned that we might start seeing resistance develop in group 4 as a result.
"BVA believes that prescribing of anthelmintics requires a level of control best provided by a veterinary surgeon who has the animals under his/her care, and is based on a sound clinical diagnosis, in order to protect animal welfare and safeguard the efficacy of these products for the future."
Further information on BVA's policy on anthelmintics can be found on BVA’s website: www.bva.co.uk/news-campaigns-and-policy/policy/medicines/anthelmintics.
Brand Manager Dr Amy Scott said: "Because pain is often very difficult for owners to spot, the website highlights some of the common signs that indicate their cat or dog is suffering.
"We have also included a range of additional measures that owners can take to improve the quality of life and maintain the joint health of their pet once Metacam has been prescribed. These include weight management, regular and gentle exercise and alternative therapies such as hydrotherapy or the use of joint supplements such as Seraquin."
The website highlights common painful conditions such as arthritis, as well as more acute scenarios such as post injury or surgery. It also describes the changes in behaviour owners should be aware of that could indicate their pet is in pain, for example reluctance to exercise, change in appetite, displays of aggression or depression.
Amy added: "The correct use of NSAIDs is also an important consideration for effective pain management. To help with this, the website contains a section on Metacam administration for owners, featuring a short video on accurate dosing and treatment."
Following last year's campaign, Merial commissioned a survey to learn more about how horse owners seek and receive information about the wider aspects of preventative healthcare, and in particular about the relationship with their veterinary practice.
In the survey of 455 horse owners, which was carried out by CMI Research, 78% said their veterinary surgeon was the most important source of information. The next most important influencers were yard managers/grooms at just 22%.
Louise Radford MRCVS from Merial said: "We wanted to learn more about client education and the opportunities for practices to get more from their client relationships, including vaccination and booster uptake. However we hadn’t estimated just how much horse owners rely on their vet for information!"
"However there appears to be a significant gap between vets as a source of information, and their client’s purchasing habits. Health plans are a great example of the potential for improved compliance, with benefits to the horse, client and practice. Yard health plans present an opportunity to increase booster uptake and also to include animals that might not otherwise be vaccinated.
"Of those horse owners and grooms surveyed who did not vaccinate some or all of their horses, their reasons included horses that never leave the yard, or are old, young, or do not interact with other horses. Yet we know that horses that don’t travel are still at risk of equine flu, as virus can travel up to a mile as an aerosol on the wind, in addition to being carried on objects such as buckets and tack.
"So as the key influencers on preventative healthcare, there is much that practices can do to further engage with clients to increase uptake of products and services, improve client loyalty, and ultimately boost the practice business."
For more information on Equine Flu Awareness Month- 2017, including client materials and video content, visit www.equinefluawareness.com
MSD says the campaign will help veterinary nurses and front-of-house staff start the conversation about parasite control by asking clients about their pets' favourite hiding places, where parasites are often found. The supporting campaign tools and materials are designed to help practice staff then uncover pet owner needs to ensure they get the best recommendation.
Amanda Melvin, Marketing Manager at MSD Animal Health said: "Vet nurses and front-of-house staff are usually the first contact pet owners have with the practice. Yet the potential they have to add value to the whole consultation process is often underestimated.
"Our ‘No Hiding’ campaign has been designed to make use of this expertise by helping them find a way of sharing their knowledge. When it comes to pet owners this is usually best achieved by sharing those conversations about the unusual quirks and habits of their pets. That way they can uncover their hiding places and give them the best advice on parasite control."
The ‘No Hiding’ campaign offers a range of resources for practices including in-practice training, social media support, and interactive waiting room resources - demonstrating the practice’s expertise and allowing pet owners to share in the unique hiding habits of their pets.
For further information, contact your MSD Animal Health account manager.
The trial is the result of a six-week consultation held by the College in June 2016, asking for the profession’s views on a proposed new system of CPD - one that concentrates less on hours logged and more on interactive, reflective learning and measuring the impact that CPD has on the individual’s practice and patient health outcomes.
The College says that while an overall majority of the 3,357 people who responded to the College’s consultation agreed with the proposed changes to the CPD requirement, certain elements received less support than others. The lowest amount of support was received for the ‘reflection’ component with 35% of respondents disagreeing with it.
The RCVS Education Committee and VN Council therefore agreed that a pilot of a new outcomes-based approach should be held during 2017 before making a recommendation to RCVS Council. The RCVS Council approved this proposal at its meeting on 10 November 2016, after which 117 volunteers were recruited, 60 of whom were able to attend the training days.
A veterinary surgeon who signed up for the pilot and works in veterinary industry, Gina Dungworth, said: "I really appreciate the acknowledgement of non-clinical CPD practices, and while I was originally sceptical of the proposed system the pilot day has so far been clear and helpful."
A veterinary nurse volunteer, Lindsey Raven Emrich, said: "CPD is such a varied part of a veterinary professional’s career, and it very much depends on the person how easy it is to do. I find myself doing a lot of reflection as a natural part of reading articles, and I’m hoping this new system will expand that way of thinking into other areas of CPD."
The volunteers will now pilot the new proposed system and report to Education Committee, VN Council and RCVS Council.
"We would like to reassure vets, and through them dog owners, that we are constantly reviewing adverse event report data to ensure that the benefits of each UK licenced veterinary medicine product outweighs the risk posed by their potential side-effects.
There are a number of vaccines authorised in the UK containing either two (L2) or four (L4) strains of Leptospira. Based on the most recent periodic safety update report data received for each product, the incidence of adverse animal reactions for all L2 vaccine products combined is 0.015%; for L4 vaccine products this figure is 0.069%.
In other words, the VMD has received fewer than 2 adverse reactions for L2, and fewer than 7 for L4, for every 10,000 doses sold. This includes every suspected adverse event reported, even cases that were considered unclassifiable or were later found to be unrelated to the vaccine.
The overall incidence of suspected adverse reactions for both L2 and L4 vaccine products is therefore considered to be rare."
The proposed withdrawal is vigorously opposed by the National Pig Association, which argues that zinc oxide is effective at controlling E.coli infections and can result in lower use of antimicrobials. Furthermore, the ban was proposed by France and the Netherlands, neither of which use zinc oxide.
The Veterinary Medicines Directorate has submitted evidence to support a proposal for a 10 year transition period if medicines containing zinc oxide are to be withdrawn. This will allow for changes in pig farming practices to avoid increases in the occurrence of diarrhoea at weaning, to ensure animal welfare and prevent increases in the use of antibiotics.
The European Commission will now make a final decision on zinc oxide products - taking into account the CVMP’s recommendation and evidence submitted by Member States - which is expected to be announced some time after June this year.
Last year's event generated an impressive amount of media coverage about ticks on Radio Four's Today programme, BBC Radio 1, 2 and 5, BBC TV Breakfast, BBC TV News, Good Morning Britain, ITV News and Channel 5 news, amongst others, providing an opportunity for practices to convert heightened public awareness into more protected pets.
Amanda Melvin, Small Animal Marketing Manager at MSD Animal Health said: "Last year’s Tick Awareness Month was a great success thanks to the high involvement of veterinary practices. We would like to give as many practices as possible the chance to get involved this year so are urging surgeries to get in touch early and we will ensure you get a pack of support resources for this nationwide event."
For further information, contact your MSD Animal Health representative or visit: www.bigtickproject.co.uk.